HIVE LAB: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HIVE LAB
Largest movements
- Receivables within one year +€2,181
up €2,181 (+243%), from €897 to €3,078
of which Other amounts receivable: +€1,525
- Cash +€1,222
up €1,222 (+155%), from €787 to €2,009
mainly Other debts (+€19,650) and Tax, wage and social debts (+€1,193)
- Tangible fixed assets -€908
down €908 (-18.5%), from €4,918 to €4,010
- Deferred charges and accrued income +€145
up €145 (+8.4%), from €1,738 to €1,883
- Other debts +€19,650
up €19,650 (+74.1%), from €26,528 to €46,178
- Profit (loss) carried forward -€18,055
down €18,055 (-54.3%), from -€33,231 to -€51,285
- Tax, wage and social debts +€1,193
up €1,193 (+887%), from €134 to €1,328
- Gross operating margin +€6,377
up €6,377 (+28.0%), from -€22,745 to -€16,368
- Other operating charges +€269
up €269 (+120%), from €223 to €492
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €8,339 | €10,980 | +€2,640 | +31.7% |
| Fixed assets | 21/28 | €4,918 | €4,010 | -€908 | -18.5% |
| Tangible fixed assets | 22/27 | €4,918 | €4,010 | -€908 | -18.5% |
| Plant, machinery and equipment | 23 | €4,918 | €4,010 | -€908 | -18.5% |
| Current assets | 29/58 | €3,422 | €6,970 | +€3,548 | +104% |
| Amounts receivable within one year | 40/41 | €897 | €3,078 | +€2,181 | +243% |
| Trade receivables | 40 | €719 | €1,375 | +€656 | +91.3% |
| Other amounts receivable | 41 | €178 | €1,703 | +€1,525 | +855% |
| Cash at bank and in hand | 54/58 | €787 | €2,009 | +€1,222 | +155% |
| Deferred charges and accrued income | 490/1 | €1,738 | €1,883 | +€145 | +8.4% |
| Total equity and liabilities | 10/49 | €8,339 | €10,980 | +€2,640 | +31.7% |
| Equity | 10/15 | -€33,231 | -€51,285 | -€18,055 | -54.3% |
| Profit (loss) carried forward | 14 | -€33,231 | -€51,285 | -€18,055 | -54.3% |
| Amounts payable | 17/49 | €41,570 | €62,265 | +€20,695 | +49.8% |
| Amounts payable within one year | 42/48 | €41,507 | €62,265 | +€20,758 | +50.0% |
| Current portion of amounts payable after more than one year | 42 | €7,567 | €7,567 | = | 0.0% |
| Trade debts | 44 | €7,278 | €7,193 | -€85 | -1.2% |
| Suppliers | 440/4 | €7,278 | €7,193 | -€85 | -1.2% |
| Taxes, remuneration and social security | 45 | €134 | €1,328 | +€1,193 | +887% |
| Taxes | 450/3 | €134 | €1,328 | +€1,193 | +887% |
| Other amounts payable | 47/48 | €26,528 | €46,178 | +€19,650 | +74.1% |
| Accrued charges and deferred income | 492/3 | €63 | - | -€63 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €908 | €908 | = | 0.0% |
| Other operating charges | 640/8 | €223 | €492 | +€269 | +120% |
| Gross operating margin | 9900 | -€22,745 | -€16,368 | +€6,377 | +28.0% |
| Operating profit (loss) | 9901 | -€23,876 | -€17,768 | +€6,108 | +25.6% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €136 | €287 | +€151 | +111% |
| Recurring financial charges | 65 | €136 | €287 | +€151 | +111% |
| Profit (loss) for the period before taxes | 9903 | -€24,011 | -€18,055 | +€5,957 | +24.8% |
| Profit (loss) for the period | 9904 | -€24,011 | -€18,055 | +€5,957 | +24.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€24,011 | -€18,055 | +€5,957 | +24.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.